GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Net Issuance of Preferred Stock

ME Therapeutics Holding (XCNQ:METX) Net Issuance of Preferred Stock : C$0.00 Mil (TTM As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

ME Therapeutics Holding's net issuance of preferred for the three months ended in Feb. 2024 was C$0.00 Mil. The number is 0, which means that ME Therapeutics Holding has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

ME Therapeutics Holding's net issuance of preferred for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.00 Mil.

ME Therapeutics Holding Net Issuance of Preferred Stock Historical Data

The historical data trend for ME Therapeutics Holding's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Net Issuance of Preferred Stock Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Net Issuance of Preferred Stock
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Net Issuance of Preferred Stock Get a 7-Day Free Trial - - - - -

ME Therapeutics Holding Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Net Issuance of Preferred Stock
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines